Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Gainers
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
- Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. The company's market cap stands at $59.8 million.
- Stealth BioTherapeutics (NASDAQ:MITO) stock increased by 11.72% to $0.91. The company's market cap stands at $52.1 million.
- Genocea Biosciences (NASDAQ:GNCA) stock increased by 10.04% to $1.37. The market value of their outstanding shares is at $78.7 million.
- Unity Biotechnology (NASDAQ:UBX) shares moved upwards by 8.97% to $1.7. The market value of their outstanding shares is at $98.1 million.
- Lucid Diagnostics (NASDAQ:LUCD) stock rose 7.31% to $5.28. The company's market cap stands at $194.3 million.
- Yield10 Bioscience (NASDAQ:YTEN) shares moved upwards by 7.23% to $5.48. The market value of their outstanding shares is at $26.7 million.
Losers
- BridgeBio Pharma (NASDAQ:BBIO) shares declined by 65.66% to $13.95 during Monday's pre-market session. The company's market cap stands at $2.0 billion.
- BiondVax Pharmaceuticals (NASDAQ:BVXV) shares decreased by 19.43% to $2.24. The market value of their outstanding shares is at $32.1 million.
- Pluristem Therapeutics (NASDAQ:PSTI) stock fell 11.35% to $1.72. The market value of their outstanding shares is at $55.2 million.
- BioCardia (NASDAQ:BCDA) shares declined by 10.44% to $2.23. The market value of their outstanding shares is at $37.6 million.
- CytomX Therapeutics (NASDAQ:CTMX) shares fell 6.84% to $3.93. The company's market cap stands at $256.5 million.
- X4 Pharmaceuticals (NASDAQ:XFOR) stock fell 5.07% to $2.35. The market value of their outstanding shares is at $57.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.